TGF-β1 Regulates Differentiation of Bone Marrow Mesenchymal Stem Cells

Vitamins and Hormones

Volumn 87, Issue , 2011, Pages 127-141

  Zhao, Longmei ^a   Hantash, Basil M ^a  

^a Escape Therapeutics Inc   (United States)

Author keywords

Bone marrow; Differentiation; Mesenchymal stem cells; TGF 1

Indexed keywords

EID: 84863420807     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386015-6.00042-1     Document Type: Chapter

References (80)

1. Akhurst R.J., et al. TGF beta in murine morphogenetic processes: The early embryo and cardiogenesis. Development 1990, 108:645-656.
2. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000, 21:667-681.
3. Arnold U., et al. In vitro-cultivation of human periosteum derived cells in bioresorbable polymer-TCP-composites. Biomaterials 2002, 23:2303-2310.
4. Becker C., et al. TGFbeta-1 and epithelial-mesenchymal interactions promote smooth muscle gene expression in bone marrow stromal cells: Possible application in therapies for urological defects. Int. J. Artif. Organs 2008, 31:951-959.
5. Behfar A., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002, 16:1558-1566.
6. Black I.B., Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol. Dis. 2001, 27:632-636.
7. Bosnakovski D., et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: Influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol. Bioeng. 2006, 93:1152-1163.
8. Bruder S.P., et al. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997, 21:225-235.
9. Campagnoli C., et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
10. Chen D., et al. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
11. Colter D.C., et al. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA 2001, 98:7841-7845.
12. De Bari C., et al. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 2003, 160:909-918.
13. De Bari C., et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum. 2008, 58:240-250.
14. Deaton R.A., et al. Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J. Biol. Chem. 2005, 280:31172-31181.
15. Derynck R. SMAD proteins and mammalian anatomy. Nature 1998, 393:737-739.
16. Devine J.H., et al. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J. Biol. Chem. 1999, 274:13604-13612.
17. Dickson M.C., et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 1995, 121:1845-1854.
18. Erices A., et al. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000, 109:235-242.
19. Friedenstein A.J., et al. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970, 3:393-403.
20. Geiser A.G., et al. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone 1998, 23:87-93.
21. Gong Z., Niklason L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 2008, 22:1635-1648.
22. Gwak S.J., et al. In vitro cardiomyogenic differentiation of adipose-derived stromal cells using transforming growth factor-beta1. Cell Biochem. Funct. 2009, 27:148-154.
23. Heim M., et al. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004, 145:848-859.
24. Hocevar B.A., et al. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999, 18:1345-1356.
25. Hock J.M., et al. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 1990, 126:421-426.
26. Hoffmann A., et al. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J. Clin. Invest. 2006, 116:940-952.
27. Hofstetter C.P., et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 2002, 99:2199-2204.
28. Hong J.H., Yaffe M.B. TAZ: A beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 2006, 5:176-179.
29. Hong J.H., et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-1078.
30. Horwitz E.M., et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
31. Ignotz R.A., Massague J. Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 1985, 82:8530-8534.
32. In't Anker P.S., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003, 102:1548-1549.
33. In't Anker P.S., et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 2003, 31:881-889.
34. In't Anker P.S., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22:1338-1345.
35. Janssens K., et al. Transforming growth factor-beta1 to the bone. Endocr. Rev. 2005, 26:743-774.
36. Jiang Y., et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 2002, 30:896-904.
37. Johnstone B., et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 1998, 238:265-272.
38. Kanematsu A., et al. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am. J. Pathol. 2005, 166:565-573.
39. Kato Y., et al. Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: Regulation by transforming growth factor beta and serum factors. Proc. Natl. Acad. Sci. USA 1988, 85:9552-9556.
40. Kennard S., et al. Transforming growth factor-beta (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J. Biol. Chem. 2008, 283:1324-1333.
41. Kinner B., et al. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp. Cell Res. 2002, 278:72-83.
42. Komori T., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
43. Kulkarni A.B., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 1993, 90:770-774.
44. Kurpinski K., et al. Proteomic profiling of mesenchymal stem cell responses to mechanical strain and TGF-beta1. Cell Mol. Bioeng. 2009, 2:606-614.
45. Lee K.S., et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 2000, 20:8783-8792.
46. Leonard C.M., et al. Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: Stimulation of mesenchymal condensation and fibronectin gene expression by exogenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev. Biol. 1991, 145:99-109.
47. Li T.S., et al. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 2005, 111:2438-2445.
48. Lieb E., et al. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. II: Osteoblastic differentiation. Tissue Eng. 2004, 10:1414-1425.
49. Liu P., et al. Regulation of osteogenic differentiation of human bone marrow stromal cells: Interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) in vitro. Calcif. Tissue Int. 1999, 65:173-180.
50. Marinova-Mutafchieva L., et al. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum. 2000, 43:2046-2055.
51. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 1990, 6:597-641.
52. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
53. Massague J., et al. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
54. Moriscot C., et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005, 23:594-603.
55. Moses H.L., Serra R. Regulation of differentiation by TGF-beta. Curr. Opin. Genet. Dev. 1996, 6:581-586.
56. Ogawa T., et al. In vitro proliferation and chondrogenic differentiation of rat bone marrow stem cells cultured with gelatin hydrogel microspheres for TGF-beta1 release. J. Biomater. Sci. Polym. Ed. 2010, 21:609-621.
57. Otto F., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
58. Owen M., Friedenstein A.J. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found. Symp. 1988, 136:42-60.
59. Park H., et al. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007, 28:3217-3227.
60. Phinney D.G., Prockop D.J. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-Current views. Stem Cells 2007, 25:2896-2902.
61. Proetzel G., et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 1995, 11:409-414.
62. Robey P.G., et al. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J. Cell Biol. 1987, 105:457-463.
63. Rosen D.M., et al. Differentiation of rat mesenchymal cells by cartilage-inducing factor. Enhanced phenotypic expression by dihydrocytochalasin B. Exp. Cell Res. 1986, 165:127-138.
64. Rosen E.D., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4:611-617.
65. Seruya M., et al. Clonal population of adult stem cells: Life span and differentiation potential. Cell Transplant. 2004, 13:93-101.
66. Seyedin S.M., et al. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J. Biol. Chem. 1986, 261:5693-5695.
67. Shull M.M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
68. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 2003, 3:807-821.
69. Timper K., et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem. Biophys. Res. Commun. 2006, 341:1135-1140.
70. Toma J.G., et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 2001, 3:778-784.
71. Tuli R., et al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J. Biol. Chem. 2003, 278:41227-41236.
72. Varelas X., et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 2008, 10:837-848.
73. Vater C., et al. Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater. 2011, 7:463-477.
74. Wakitani S., et al. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995, 18:1417-1426.
75. Xia W., et al. Adenoviral transduction of hTGF-beta1 enhances the chondrogenesis of bone marrow derived stromal cells. Biotechnol. Lett. 2009, 31:639-646.
76. Xiao Y., et al. Clonal characterization of bone marrow derived stem cells and their application for bone regeneration. Int. J. Oral Sci. 2010, 2:127-135.
77. Xu C., et al. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Endocrinology 1996, 137:3557-3565.
78. Yu L., et al. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 2002, 21:3749-3759.
79. Zhao L., et al. Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue Eng. Part A 2010, 16:725-733.
80. Zuk P.A., et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.